Important note

This AI stock analysis for Teladoc Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Teladoc Health - AI Stock Analysis

Analysis generated March 10, 2025

Teladoc Health (NYSE: TDOC) is a leading provider of telemedicine and virtual healthcare services. The company offers a wide range of services including remote consultations, mental health services, and chronic condition management. Teladoc utilizes a proprietary technology platform to connect patients with healthcare professionals, making healthcare more accessible and convenient. As a pioneer in the telehealth space, Teladoc aims to leverage technology to provide better healthcare outcomes and expand access to medical services.

Fundamental Analysis

Teladoc Health reported a revenue of $641 million in the last quarter. This represents a slight decrease of 0.30% compared to the previous quarter and a more significant decrease of 2.15% compared to the same quarter last year. While these figures indicate some pressure on top-line growth, the overall revenue performance is still substantial for the industry.

The company's net income for the last quarter was $33 million, a notable increase of 96.03% compared to the previous quarter, and a yearly increase of 41.70%. This improvement in net income signals enhanced profitability and operational efficiency.

EBITDA for the last quarter was $63 million, showing an impressive increase of 108.58% from the previous quarter and a year-over-year rise of 55.32%. This positive EBITDA growth highlights Teladoc's strong financial health and its ability to generate profits before interest, taxes, depreciation, and amortization.

However, there have been insider stock sales in recent months, which can be a bearish signal suggesting that company insiders might be losing confidence in the stock's future performance.

Technical Analysis

Teladoc Health's current stock price is $8.93, down 35.57% from a month ago, and a decrease of 42.72% from a year ago. These declines indicate short- and long-term concerns regarding the stock's performance.

The stock's current Simple Moving Average (SMA10) is $9.26, slightly lower than the previous SMA10 of $9.32. This suggests a potential downward trend in price movement, heightening bearish sentiments. The Relative Strength Index (RSI) is at 37.2, indicating a neutral condition but precariously close to being oversold.

Alternative Data Analysis

Based on job postings data from popular job boards, Teladoc Health has 98 open positions, a stable number over the past few months. This stability suggests a steady organizational structure.

Employee sentiment at Teladoc Health is relatively low, with only 41% having a positive outlook on the business, a concerning sign that can affect overall productivity and morale.

The company's web traffic is estimated at 910,000 visitors, down by 8% in recent months, indicating potential customer attrition. Additionally, daily app downloads are estimated at 1,600, down by 28% over the same period, further compounding concerns about customer retention.

On social media, Teladoc Health has 13,000 followers on Instagram, an increase of 5% over recent months, which is a positive sign of growing interest. On Twitter, the company has 18,000 followers, with no significant changes in recent months.

Lastly, AltIndex's AI score for Teladoc Health is 49, which translates to a hold signal. This score consolidates various indicators to provide a balanced perspective on the stock's future performance.

Conclusion & Recommendation

While Teladoc Health shows strong profitability improvements with significant gains in net income and EBITDA, its revenue is showing signs of stagnation. The technical indicators are predominantly bearish, and the alternative data points, such as job postings and employee sentiment, show a mixed picture. Given these factors and the AltIndex AI score of 49, which suggests holding the stock, it seems prudent to adopt a cautious approach. Prospective investors should keep a close eye on future financial performances and market conditions before making any investment decisions.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.